Efficacy and Safety of Fixed-Dose-Rate Infusions of Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer. J. Anal. Oncol. 2015;4(1): 44-51. doi:10.6000/1927-7229.2015.04.01.8